Advanced company searchLink opens in new window

CELGENE LIMITED

Company number 05470441

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
10 Oct 2024 AA Full accounts made up to 31 December 2023
21 May 2024 RP04CS01 Second filing of Confirmation Statement dated 6 May 2023
15 May 2024 CS01 Confirmation statement made on 6 May 2024 with updates
17 Nov 2023 TM01 Termination of appointment of John Scott Cooke as a director on 8 November 2023
17 Nov 2023 AP01 Appointment of Annie Ong as a director on 8 November 2023
29 Sep 2023 SH19 Statement of capital on 29 September 2023
  • GBP 2
29 Sep 2023 SH20 Statement by Directors
29 Sep 2023 CAP-SS Solvency Statement dated 28/09/23
29 Sep 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Cancel share premium 28/09/2023
07 Aug 2023 AA Full accounts made up to 31 December 2022
24 Jul 2023 CH01 Director's details changed for Director Kimberly Mccutcheon Jablonski on 1 July 2023
19 May 2023 CS01 Confirmation statement made on 6 May 2023 with no updates
  • ANNOTATION Clarification a second filed CS01 (Statement of Capital, Shareholder information) was registered on 21/05/24
03 Oct 2022 TM01 Termination of appointment of Teresa Maria Vargas Quintas Campos as a director on 3 October 2022
29 Sep 2022 PSC05 Change of details for Bristol-Myers Squibb Pharmaceuticals Limited as a person with significant control on 23 September 2022
23 Sep 2022 AD01 Registered office address changed from Arc Uxbridge Sanderson Road New Denham, Denham Uxbridge Buckinghamshire UB8 1DH England to Arc Uxbridge Sanderson Road New Denham Denham Buckinghamshire UB8 1DH on 23 September 2022
23 Sep 2022 AD01 Registered office address changed from Uxbridge Business Park Sanderson Road Uxbridge Middlesex UB8 1DH England to Arc Uxbridge Sanderson Road New Denham, Denham Uxbridge Buckinghamshire UB8 1DH on 23 September 2022
17 Aug 2022 PSC02 Notification of Bristol-Myers Squibb Pharmaceuticals Limited as a person with significant control on 31 July 2022
17 Aug 2022 PSC07 Cessation of Celgene Uk Manufacturing (Ii) Limited as a person with significant control on 31 July 2022
14 Jun 2022 AA Full accounts made up to 31 December 2021
16 May 2022 CS01 Confirmation statement made on 6 May 2022 with no updates
09 Feb 2022 AP01 Appointment of Director Kimberly Mccutcheon Jablonski as a director on 19 January 2022
09 Feb 2022 TM01 Termination of appointment of David Walter Pignolet as a director on 19 January 2022
09 Feb 2022 TM01 Termination of appointment of Katherine Reynolds Kelly as a director on 17 September 2021
19 Nov 2021 AA Full accounts made up to 31 December 2020
04 Oct 2021 AD01 Registered office address changed from 1 Longwalk Road, Stockley Park Uxbridge Middlesex UB11 1DB to Uxbridge Business Park Sanderson Road Uxbridge Middlesex UB8 1DH on 4 October 2021